World Vaccine Congress, Europe

Following up WVC in Washington during the spring CSO Anna-Karin Maltais and CEO Hans Arwidsson will present the latest progress from development of Immunose™ FLU, our first vaccine candidate, based on our technology platform Endocine™ This conference is about research, development and strategic partnering for the global vaccine industry. Read more here =>  

Read More

World Vaccine Congress, Washington

One of the most important conferences in the North American vaccine industry is the annual WVC in Washington. Here, scientists and decision makers meet to discuss the latest innovation and development. Eurocine Vaccines´ CSO, Dr. Anna-Karin Maltais, will contribute with the latest results from our clinical study with Immunose™ FLU, our first product candidate based on

Read More

BIO Europe Spring 2018, Amsterdam

At least one executive from the Management Team of Eurocine Vaccines will be present at this partnering conference to meet and discuss the latest development in nasal vaccination and specifically present recent results from the clinical study with Immunose™ FLU – our first candidate based on the technology platform Endocine™.   If you plan attending the conference

Read More

Investors Conference – Biotech and Money, London

Eurocine Vaccines has been specially invited to speak at this years annual industry conference for investors of BioTech and Life Science on the topic “At the forefront of Nasal Vaccination” Please reach out to CEO Hans Arwidsson if you plan to attend the conference in order to book a meeting => What is Biotech and Money?

Read More

Årsstämma

Välkommen till årsstämma torsdagen den 14 december 2017 kl. 16.00 på Scandic Järva Krog med adress Vallgatan 2, i Solna. Anmälan enligt separat kallelse.

Read More

Aktiedagen Stockholm

Kom till Aktiedagen för att lyssna till VD Hans Arwidsson och forskningschef Anna-Karin Maltais och ställ dina frågor på plats. Hotel Birger Jarl, Birger Jarlsgatan 61A, Stockholm.

Read More

Mingel & Börsanalys

Eurocine Vaccines har bjudits in att berätta hur vår vision driver oss att utveckla det första nasala barnvaccinet för investerare på Financial Stockholm, Hotell Anglais vid Stureplan. Se inbjudan =>

Read More

Do you want to follow Eurocine Vaccines development?

Share our ambition developing more effective vaccines. Fill in your e-mail address and we will update you with the latest Press Releases and Stories.

Start your subscription here »